Luis
Bujanda Fernández de Piérola
Fundación Jiménez Díaz
Madrid, EspañaPublications in collaboration with researchers from Fundación Jiménez Díaz (4)
2023
-
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study
Alimentary Pharmacology and Therapeutics, Vol. 58, Núm. 1, pp. 60-70
2022
-
A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer
Gastroenterology, Vol. 163, Núm. 5, pp. 1242-1251.e2
2021
-
Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview
Molecular Diagnosis and Therapy, Vol. 25, Núm. 5, pp. 563-576
2015
-
Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastricneuroendocrine tumour
Human Molecular Genetics, Vol. 24, Núm. 10, pp. 2914-2922